Thyrocare Technologies Limited has informed the Exchange regarding Appointment of Mr Vikram Gupta as Chief Financial Officer of the company w.e.f. July 24, 2025.
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 12.1 pts more than Nifty Microcap 250 and 11.0 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Thyrocare Technologies reported strong Q1 FY26 results with consolidated revenue from operations of Rs. 193.03 crores, up from Rs. 156.91 crores in Q1 FY25 (about 23% growth year-on-year). Net profit surged to Rs. 38.29 crores versus Rs. 23.94 crores in the same quarter last year, with basic EPS of Rs. 7.22. The Board approved a CFO change: Mr. Alok Kumar Jagnani stepped down as CFO (he moves up to become Group CFO of parent API Holdings and joins Thyrocare's board as a Non-Executive Director), and Mr. Vikram Gupta, a Chartered Accountant with prior experience at Rebel Foods, Tata Play Fiber, and Vodafone Idea, was appointed as the new CFO effective July 24, 2025. Non-Executive Director Mr. Hardik Dedhia also resigned citing pre-occupation, and VP Franchisee Operations Mr. Amit Bhola will leave on July 31, 2025.
Strong quarter with healthy revenue and profit growth should be viewed positively by shareholders. The CFO transition is essentially a role shuffle within the API Holdings group rather than an external exit, which should help maintain continuity. Director and senior management changes are routine housekeeping and unlikely to materially impact the stock.